Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory Arthritis

NCT04261023 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class

Stopped The CI terminated ARCADIA early due to a number of reasons. These include the difficulty in recruiting and being placed on pause during the COVID pandemic, plus limited staffing at that time \& the need to considerably amend the eCRF MACRO system

Conditions

Interventions

Sponsor

University of Leeds